Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -9 of 9
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
12/1/1992
1.
Phase II Trial of Rhizoxin in Patients with Advanced Ovarian Cancer (Summary Last Modified 12/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
CRC-PHASE-II-PH2/024
Last Modified:
9/1/1992
2.
Phase II Trial of Rhizoxin in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 09/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
CRC-PHASE-II-PH2/025
Last Modified:
12/1/1992
3.
Phase II Trial of Rhizoxin in Patients with Advanced Colorectal Cancer (Summary Last Modified 12/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
CRC-PHASE-II-PH2/023
Last Modified:
11/1/1993
4.
Phase II Study of Rhizoxin in Patients with Advanced Nonsmall Cell Lung Cancer (Summary Last Modified 11/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
EORTC-16912N
Last Modified:
9/1/1993
5.
Phase II Study of Rhizoxin in Patients with Advanced Malignant Melanoma (Summary Last Modified 09/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
EORTC-16912M
Last Modified:
9/1/1993
6.
Phase II Study of Rhizoxin in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 09/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
EORTC-16912H
Last Modified:
9/1/1993
7.
Phase II Study of Rhizoxin in Patients with Advanced Breast Cancer (Summary Last Modified 09/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
EORTC-16912B
Last Modified:
5/1/1998
8.
Phase I Study of Rhizoxin Administered as a 72-Hour Continuous Infusion with or without G-CSF for Malignant Solid Tumors Including Lymphomas (Summary Last Modified 05/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
UCCRC-7265
NCI-T94-0004H, T94-0004
Last Modified:
11/1/1998
9.
Phase I Study of Rhizoxin Administered as a 72-Hour Continuous Infusion Every 21 Days for Advanced Malignancies (Summary Last Modified 11/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
UTHSC-9345011494
NCI-T94-0124D, T94-0124
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute